or Try an Advanced Search...

    Therapeutic Gene Modulation Stocks List

    Symbol Grade Name % Change
    ALNY B Alnylam Pharmaceuticals, Inc. 0.13
    SRPT B Sarepta Therapeutics, Inc. -0.79
    IONS B Ionis Pharmaceuticals, Inc. -1.15
    PRQR F ProQR Therapeutics B.V. -0.60
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Biotechnology Alnylam Pharmaceuticals Amyloid Amyloidosis Antisense RNA Cholesterol Clinical Development Dystrophy Huntington's Disease Hypercholesterolemia Life Sciences Rare Diseases Spinal Muscular Atrophy Acromegaly Acute Intermittent Porphyria Alcohol Alpha 1 Antitrypsin Deficiency Alport Syndrome Angioedema

    Related ETFs - A few ETFs which own one or more of the above listed Therapeutic Gene Modulation stocks.

    Symbol Grade Name Weight
    PINK A Simplify Health Care ETF 10.39
    BTEC B Principal Healthcare Innovators Index ETF 9.93
    GNOM C Global X Genomics & Biotechnology ETF 7.83
    XBI B SPDR S&P Biotech ETF 7.4
    BBP B BioShares Biotechnology Products Fund 6.31
    View all Therapeutic Gene Modulation ETFs...
    Compare ETFs
    Compare BTEC to BBP Compare BTEC to GNOM Compare PINK to XBI

        Therapeutic Gene Modulation Stocks Recent News

        Date Stock Title
        Jul 1 ALNY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
        Jun 30 ALNY Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?
        Jun 29 ALNY Selling US$7.7m Of Alnylam Pharmaceuticals Stock Rewarded Insiders
        Jun 27 ALNY Peering Into Alnylam Pharmaceuticals's Recent Short Interest
        Jun 27 SRPT Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
        Jun 27 ALNY Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
        Jun 26 IONS FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
        Jun 26 SRPT Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.
        Jun 26 SRPT Sarepta cut to Neutral at Citi on risks to valuation
        Jun 26 SRPT Insider Sale: EVP, General Counsel Ryan Brown Sells 38,957 Shares of Sarepta Therapeutics Inc (SRPT)
        Jun 25 IONS Ionis gains as anti-lipid therapy undergoes FDA priority review
        Jun 25 ALNY Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
        Jun 25 ALNY Top Three US Stocks Estimated Below Intrinsic Value In June 2024
        Jun 25 IONS Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
        Jun 25 ALNY RNAi: Winning In The Clinic, Now For The Market
        Jun 25 IONS Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
        Jun 25 ALNY Nvidia, Affirm Holdings, Carnival Corp, Alnylam Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Biotechnology Alnylam Pharmaceuticals Amyloid Amyloidosis Antisense RNA Cholesterol Clinical Development Dystrophy Huntington's Disease Hypercholesterolemia Life Sciences Rare Diseases Spinal Muscular Atrophy Acromegaly Acute Intermittent Porphyria Alcohol Alpha 1 Antitrypsin Deficiency Alport Syndrome Angioedema
        Therapeutic Gene Modulation

        Therapeutic gene modulation is a type of gene therapy that involves altering the expression of a gene in order to treat a disease or condition. This can be done by introducing a new gene, or by manipulating the expression of an existing gene. Examples of therapeutic gene modulation include using gene editing techniques such as CRISPR/Cas9 to modify a gene, or using gene therapy to introduce a new gene into a cell.

        Browse All Tags